0001144204-19-015117.txt : 20190320 0001144204-19-015117.hdr.sgml : 20190320 20190320160751 ACCESSION NUMBER: 0001144204-19-015117 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180318 FILED AS OF DATE: 20190320 DATE AS OF CHANGE: 20190320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PRZYBYL ARTHUR CENTRAL INDEX KEY: 0001268135 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 19694735 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001023024 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 582301143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 BUSINESS PHONE: 2186343500 MAIL ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 FORMER COMPANY: FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19991228 FORMER COMPANY: FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC DATE OF NAME CHANGE: 19991027 4 1 tv516671_form4.xml FORM 4 X0306 4 2018-03-18 0 0001023024 ANI PHARMACEUTICALS INC ANIP 0001268135 PRZYBYL ARTHUR C/O ANI PHARMACEUTICALS, INC. 210 MAIN STREET WEST BAUDETTE MN 56623 1 1 0 0 President and CEO Common Stock 2019-03-18 4 S 0 24802 63.53 D 205076 D Common Stock 2019-03-19 4 S 0 2823 63.51 D 205076 D Stock Options 33.00 2019-03-18 4 M 0 6375 0 D 2024-03-31 Common Stock 6375 0 D Stock Options 40.59 2019-03-18 4 M 0 9375 0 D 2026-04-06 Common Stock 9375 18750 D Stock Options 49.51 2019-03-18 4 M 0 9052 0 D 2027-03-30 Common Stock 9052 38448 D Stock Options 49.51 2019-03-19 4 M 0 2823 0 D 2027-03-30 Common Stock 2823 35625 D The shares were sold in multiple trades at prices ranging from $63.49 to $64.06. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The reporting person owns 205,076 shares of the Issuer's common stock following the transaction, which is the same number of shares reported on his most recent prior filing. The shares were sold in multiple trades at prices ranging from $63.49 to $63.60. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The reporting person owns 205,076 shares of the Issuer's common stock following the transaction, which is the same number of shares reported on his most recent prior filing. Option vests and are exercisable over a four year period beginning on the first anniversary of April 1, 2014. Option vests and are exercisable over a four year period beginning on the first anniversary of April 7, 2016. Option vests and are exercisable over a four year period beginning on the first anniversary of March 31, 2017. /s/ Arthur Przybyl 2019-03-20